Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to N…
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Estimated
~$10 – $8,750
Akero Therapeutics, IncNCT06528314
Observational
Non-Invasive Quantification of Liver Health in NASH (N-QUAN): A Prospective Diagnostic Accuracy Study
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those …
NASH - Nonalcoholic Steatohepatitis
Estimated
~$10 – $7,500
PerspectumNCT04054310
Observational
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
Participants meeting study entry criteria are randomized with equal probability to one of two study groups: (1) Lifestyle modification or (2) Vertical Sleeve G…
NASH - Nonalcoholic Steatohepatitis
Estimated
~$10 – $6,250
University of MinnesotaNCT03587831
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1
This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how…
Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation
Estimated
~$10 – $750
Mayo ClinicNCT04232566